1. Home
  2. MYSZ vs INM Comparison

MYSZ vs INM Comparison

Compare MYSZ & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

N/A

Current Price

$0.61

Market Cap

2.2M

Sector

Technology

ML Signal

N/A

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

N/A

Current Price

$0.82

Market Cap

2.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYSZ
INM
Founded
1999
1981
Country
Israel
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.7M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MYSZ
INM
Price
$0.61
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.1K
77.1K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$142,000.00
$4,942,633.00
Revenue This Year
$18.06
N/A
Revenue Next Year
$36.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
125.40
7.50
52 Week Low
$0.50
$0.73
52 Week High
$3.04
$7.98

Technical Indicators

Market Signals
Indicator
MYSZ
INM
Relative Strength Index (RSI) 51.41 47.32
Support Level $0.51 $0.73
Resistance Level $1.22 $1.40
Average True Range (ATR) 0.05 0.07
MACD 0.02 0.01
Stochastic Oscillator 69.81 66.98

Price Performance

Historical Comparison
MYSZ
INM

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: